185 related articles for article (PubMed ID: 22848177)
21. Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability.
Sajjad M; Khan MI; Naveed S; Ijaz S; Qureshi OS; Raza SA; Shahnaz G; Sohail MF
AAPS PharmSciTech; 2019 Jan; 20(2):81. PubMed ID: 30645705
[TBL] [Abstract][Full Text] [Related]
22. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Wu J; Shen Q; Fang L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
Liu D; Wang L; Liu Z; Zhang C; Zhang N
J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
[TBL] [Abstract][Full Text] [Related]
24. Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability.
Chen Y; Chen C; Zheng J; Chen Z; Shi Q; Liu H
Biol Pharm Bull; 2011; 34(2):278-86. PubMed ID: 21415541
[TBL] [Abstract][Full Text] [Related]
25. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
[TBL] [Abstract][Full Text] [Related]
26. The efficiency and mechanism of a new absorption enhancer, malic acid, for enhancing the oral bioavailability of docetaxel.
Guo XH; Ding F; Lian X; Cui W; Li Z; Xing Y
Pharm Dev Technol; 2021 Jun; 26(5):592-598. PubMed ID: 33734909
[TBL] [Abstract][Full Text] [Related]
27. Preparation of Deoxycholate-Modified Docetaxel-Cimetidine Complex Chitosan Nanoparticles to Improve Oral Bioavailability.
Xu Y; Fang T; Yang Y; Sun L; Shen Q
AAPS PharmSciTech; 2019 Sep; 20(7):302. PubMed ID: 31489504
[TBL] [Abstract][Full Text] [Related]
28. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study.
Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X
Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386
[TBL] [Abstract][Full Text] [Related]
29. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
Cho HJ; Park JW; Yoon IS; Kim DD
Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
[TBL] [Abstract][Full Text] [Related]
30. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
31. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
32. An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma.
Xu HL; Mao KL; Lu CT; Fan ZL; Yang JJ; Xu J; Chen PP; ZhuGe DL; Shen BX; Jin BH; Xiao J; Zhao YZ
Biomaterials; 2016 Nov; 107():44-60. PubMed ID: 27614158
[TBL] [Abstract][Full Text] [Related]
33. Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.
Chang CE; Hsieh CM; Chen LC; Su CY; Liu DZ; Jhan HJ; Ho HO; Sheu MT
Drug Deliv; 2018 Nov; 25(1):632-643. PubMed ID: 29463123
[TBL] [Abstract][Full Text] [Related]
34. Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy.
Cui W; Zhao H; Wang C; Chen Y; Luo C; Zhang S; Sun B; He Z
Drug Deliv; 2019 Dec; 26(1):542-550. PubMed ID: 31090467
[TBL] [Abstract][Full Text] [Related]
35. Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors.
Su CY; Chen M; Chen LC; Ho YS; Ho HO; Lin SY; Chuang KH; Sheu MT
Drug Deliv; 2018 Nov; 25(1):1066-1079. PubMed ID: 29718725
[TBL] [Abstract][Full Text] [Related]
36. Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor.
Shaw TK; Mandal D; Dey G; Pal MM; Paul P; Chakraborty S; Ali KA; Mukherjee B; Bandyopadhyay AK; Mandal M
Drug Deliv; 2017 Nov; 24(1):346-357. PubMed ID: 28165821
[TBL] [Abstract][Full Text] [Related]
37. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z
Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration.
Kim JH; Shin DH; Kim JS
Arch Pharm Res; 2018 Jul; 41(7):765-775. PubMed ID: 29961194
[TBL] [Abstract][Full Text] [Related]
40. Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: in vitro characteristics and in vivo performance.
Fang G; Tang B; Liu Z; Gou J; Zhang Y; Xu H; Tang X
Eur J Pharm Sci; 2014 Aug; 60():1-9. PubMed ID: 24815943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
